astrazeneca - dofaq.co
AstraZeneca admits for first time its Covid vaccine can cause rare side effect
The Telegraph - 28 Apr 2024
AstraZeneca admits for first time its Covid vaccine can cause rare side effect ...
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain'
Yahoo Finance - 25 Apr 2024
AstraZeneca CEO on US-China tensions: 'We have established a very resilient supply chain' ...
AstraZeneca CEO says platform deals largely done after M&As in vaccines, radioligand, cell therapy
FiercePharma - 25 Apr 2024
AstraZeneca CEO says platform deals largely done after M&As in vaccines, radioligand, cell therapy ...
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1
BioSpace - 25 Apr 2024
Sanofi and AstraZeneca Scrap Several Early-Stage Programs in Q1 ...
J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade
Seeking Alpha - 28 Apr 2024
J&J, Roche, AstraZeneca poised to have highest orphan drug sales by end of decade ...
AstraZeneca Admits Its Vaxxes Cause Clots
Newsmax - 28 Apr 2024
AstraZeneca Admits Its Vaxxes Cause Clots ...
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance
Yahoo Finance - 25 Apr 2024
AstraZeneca Posts Bumper Earnings On Strong Sales From Cancer Drugs, Sticks To Annual Guidance ...
AstraZeneca leaps after smashing first-quarter forecasts
Reuters.com - 25 Apr 2024
AstraZeneca leaps after smashing first-quarter forecasts ...
The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca
The Guardian - 11 Apr 2024
The danger in saying yes to Pascal Soriot’s pay rise at AstraZeneca ...
AstraZeneca shareholders approve CEO Soriot's £18.7mn pay despite revolt
Financial Times - 11 Apr 2024
AstraZeneca shareholders approve CEO Soriot's £18.7mn pay despite revolt ...
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript
The Motley Fool - 25 Apr 2024
AstraZeneca Plc (AZN) Q1 2024 Earnings Call Transcript ...
AstraZeneca Gets a Boost From Sales of Its Cancer Drugs
Investopedia - 25 Apr 2024
AstraZeneca Gets a Boost From Sales of Its Cancer Drugs ...
AstraZeneca Stock Flirts With Breakout As Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge
Investor's Business Daily - 25 Apr 2024
AstraZeneca Stock Flirts With Breakout As Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge ...
AstraZeneca’s Profit Gains on Sales of Cancer Drugs
Bloomberg - 25 Apr 2024
AstraZeneca’s Profit Gains on Sales of Cancer Drugs ...
AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs
Fortune - 25 Apr 2024
AstraZeneca encounters a surge in shares as profits exceed expectations, buoyed by demand for cancer drugs ...
AstraZeneca and Merck's Lynparza set to 'dominate' PARP market as it looks to grow cancer offerings with 100-plus ...
FiercePharma - 24 Apr 2024
AstraZeneca and Merck's Lynparza set to 'dominate' PARP market as it looks to grow cancer offerings with 100-plus ... ...
AstraZeneca posts $2.18bn profit after tax in Q1 2024
Pharmaceutical Technology - 26 Apr 2024
AstraZeneca posts $2.18bn profit after tax in Q1 2024 ...
AstraZeneca drops GOLDILOX and the porcupine in R&D update
Fierce Biotech - 25 Apr 2024
AstraZeneca drops GOLDILOX and the porcupine in R&D update ...
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief
Financial Times - 25 Apr 2024
Europe falling behind US and China in pharma innovation, warns AstraZeneca chief ...